CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company
Passage BIO, Inc.
Sign in to watch- Ticker
- PASG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822729751
- Phone
- 2678660312
- Business address
- ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-27 | Morris Richard Steven Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +74,311 | 74,311 | ||
| 2020-02-27 | Quigley Jill M. Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +211,001 | 211,001 | ||
| 2020-02-27 | SQUINTO STEPHEN P Head of Research and Dev | Grant or award · Employee Stock Option (Right to Buy) | +185,776 | 185,776 | ||
| 2020-02-27 | SQUINTO STEPHEN P Head of Research and Dev | Grant or award · Director Stock Option (Right to Buy) | +33,836 | 33,836 |
Page 14 of 14 · 264 trades